Unlocking Hidden Revenues: The Hunt for Stealth Biotechs
2022 had big shoes to fill: As many of us already know, 2021 was a record year for cash injections in the life sciences sector. This was especially true for startups, where we saw $72 billion distributed across 2100 emerging biotech & pharma companies.
While these numbers might jump off your screen, surfacing the individual companies that make up this group can be quite a tedious process… But it doesn’t have to be that way.
Ready for your guide?
What's in the guide?
Our goal in building this guide was to create a starting point for business development & sales professionals looking to explore the stealth biotech industry.
As the industry-leading sales intelligence platform crafted specifically for companies who sell into biotech & pharma, Zymewire is uniquely positioned to uncover hidden opportunities you can act on today.
Nine Stealth Biotechs
Grouped into three geographic regions (spanning the globe) and three categories
Company Breakdowns
Find out what these organizations are up to, and more importantly, what they're planning
Market Overview
Get a bird's eye view of the current state of the stealth biotech industry and how it's evolving
Stealth Spectrum
The definition of a "stealth biotech" is fluid, so we grouped them into three classes based on distinct milestones